HMG CoA reductase inhibition reduces sarcolemmal Na+-K+ pump density

Cardiovascular Research

Volumn 47, Issue 2, 2000, Pages 329-335

  Gray, David F ^a,b   Bundgaard, Henning ^c   Hansen, Peter S ^a,b   Buhagiar, Kerrie A ^a,b   Mihailidou, Anastasia S ^a   Jessup, Wendy ^d   Kjeldsen, Keld ^c   Rasmussen, Helge H ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Copenhagen   (Denmark)

^d HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Cell culture isolation; Cholesterol; Lipid metabolism; Membrane transport; Na K Pump

Indexed keywords

4 NITROPHENYLPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; OUABAIN; VANADIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL MEMBRANE; ENZYME INHIBITION; FEMALE; LIPID METABOLISM; MALE; MEMBRANE TRANSPORT; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PUMP; RABBIT; RAT; SARCOLEMMA; SKELETAL MUSCLE;

4-NITROPHENYLPHOSPHATASE; ANIMALS; CELL MEMBRANE; CHOLESTEROL; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID METABOLISM; LOVASTATIN; MALE; MEVALONIC ACID; MUSCLE, SKELETAL; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; PATCH-CLAMP TECHNIQUES; POTASSIUM; RABBITS; RATS; RATS, WISTAR; SARCOLEMMA; SODIUM;

EID: 0033900398     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00106-1     Document Type: Article

References (27)

1. Bundgaard H., Kjeldsen K. Human myocardial Na, K-ATPase concentration in heart failure. Moll Cell Biochem. 163/164:1996;277-283.
2. Cornelius F. Functional reconstitution of the sodium pump. Kinetics of exchange reactions performed by reconstituted Na/K-ATPase. Biochim Biophys Acta. 1071:1991;19-66.
3. + antiport of SV40-virus-transformed human MRC5 fibroblasts. Clin Sci. 84:1993;633-643.
4. Dørup I., Skajaa K., Clausen T. A simple and rapid method for the determination of the concentrations of magnesium, sodium, potassium and sodium, potassium pumps in human skeletal muscle. Clin Sci. 74:1988;241-248.
5. Ecay T.W., Valentich J.D. Lovastatin inhibits cAMP- and calcium-stimulated chloride secretion by T84 cells. Am J Physiol. 265:1993;C422-C431. Cell Physiol 34.
6. + pump current in guinea-pig ventricular myocytes by a cAMP-dependent PKA pathway. J Physiol. 477:1994;373-380.
7. Geering K. The functional role of the β-subunit in the maturation and intracellular transport of Na. K-ATPase. FEBS Lett. 285:1991;189-193.
8. Gelissen I.C., Brown A.J., Mander E.L., Kritharides L., Dean R.T., Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketosterol. J Biol Chem. 271:1996;17852-17860.
9. + pump function in rabbit cardiac myocytes. Am J Physiol. 272:1997;H1680-H1689. Heart Circ Physiol 41.
10. + pumping in cardiac myocytes. Am J Physiol. 268:1995;C366-C375. Cell Physiol 37.
11. + pump via effects on angiotensin metabolism. Am J Physiol. 271:1996;C172-C180. Cell Physiol 40.
12. 3 Na K-ATPase complexes in xenopus oocytes. J Biol Chem. 267:1992;577-585.
13. 3H]ouabain binding. Biochem J. 240:1986;725-730.
14. 3H]ouabain-binding sites and sodium and potassium contents in rat skeletal muscle. Br J Nutr. 56:1986;519-532.
15. Kornbrust D.J., MacDonald J.S., Chennekatu P.P., et al. Toxicity of the HMG-Coenzyme A reductase inhibitor lovastatin to rabbits. J Pharmacol Exp Ther. 248:1989;498-505.
16. +-dependent pNPPase. Age-dependent changes. Basic Res Cardiol. 90:1995;323-331.
17. 1 cells through a cAMP dependent mechanism. Mol Cell Endocrinol. 130:1997;93-100.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193:1951;265-275.
19. Ma P.T.S., Gil G., Südhof T.C., Bilheimer D.W., Goldstein J.L., Brown M.S. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptors in livers of hamsters and rabbits. Proc Natl Acad Sci USA. 83:1986;8370-8374.
20. + pumping in isolated atrial tissue from patients treated with digoxin. J Pharmacol Exp Ther. 252:1990;60-64.
21. Roullet J.-B., Xue H., Pappu A.S., et al. Mevalonate availability affects human and rat resistance vessels function. J Clin Invest. 96:1995;239-244.
22. Sinensky M., Beck L.A., Leonard S., Evans R. Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J Biol Chem. 265:1990;19937-19941.
23. Sokaloff L., Rothblatt G.H. Sterol to phospholipid molar ratios of L cells with qualitative and quantitative variations of cellular cholesterol. Proc Soc Exp Biol Med. 146:1974;1166-1172.
24. + pump activity in mammalian cardiac myocytes. Am J Physiol. 265:1993;C1201-C1210. Cell Physiol. 34.
25. Willis P.A., Folkers K., Tucker J.L., Ye C.Q., Xia U., Tamagawa H. Lovastatin decreases coenzyme Q levels in rats. Proc Natl Acad Sci USA. 87:1990;8928-8930.
26. Yeagle P.L. Modulation of membrane function by cholesterol. Biochimie. 73:1991;1303-1310.
27. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem. 274:1999;19323-19328.